Valuation
- Market cap
- 2,496,000
- Revenue TTM
- $0
- Net income TTM
- $-16,720,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 27,900
- Avg volume
- 1,069,866
- Day's range
- $2.50 – $2.64
- Shares out
- 971,000
- Stochastic %K
- 0%
- Beta
- -0.96
- Analysts
- Strong Sell
- Price target
- $58.81
Company profile
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and...
Show more
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 713 588 6150
- Website
- https://autonomix.com
- Address
- 21 Waterway Avenue, Suite 300, The Woodlands, United States
Latest news
No headlines yet.
